Where does DNA Script's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across DNA Script's 1 recorded funding rounds.

Premier Alternatives

DNA Script

Biotechnology · Paris, France · Founded 2014 · Privately Held (backing)

Developer of DNA printer technology designed to print synthetic nucleic acids for genomics and molecular biology applications. DNA Script is based in Paris, France and was founded in 2014. It was valued at $660 million at its later-stage round in Jan 2022, the last priced event on record. It has raised $299 million across 1 recorded round; the latest was a $192 million Series C in Jan 2022.

PMV mark · valuation

$659.7M

Oct 2026

Priced at

its later-stage round

Jan 2022

Total raised

$298.7M

Last round

Later Stage VC (Series C)

Jan 2022

Cap table — not yet on record

DNA Script's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of DNA Script with a free account

·The complete investor list: 34 names
·Watch DNA Script: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about DNA Script

Where does DNA Script's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across DNA Script's 1 recorded funding rounds.